SCHEMBL4602976

SCHEMBL4602976

C=CC(=O)Oc1c(O)cccc1OCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.50
ADRA1D P25100 1/20 0.50
ADRA1A P35348 1/20 0.50
ADRA1B P35368 1/20 0.50
GAA P10253 1/20 0.44
SGMS2 Q8NHU3 2/20 0.44
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
PTGER1 P34995 1/20 0.43
PTGER4 P35408 1/20 0.43
PTGER3 P43115 1/20 0.43
PTGER2 P43116 1/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
PTPN1 P18031 1/20 0.42
MCL1 Q07820 1/20 0.42
APP P05067 1/20 0.42
NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27849251 0.85 NPC1 (0.53) HTR1AGAASGMS2KMT2APTGER1
SCHEMBL4603320 0.83 MAPT (0.43) SGMS2KMT2APTGER1PTGER4PTGER3
SCHEMBL6026935 0.83 NPC1 (0.51) GAASGMS2PTGER1PTGER4PTGER3
SCHEMBL4602183 0.82 EGFR (0.47) HTR1AADRA1DADRA1AADRA1BGAA
SCHEMBL27866136 0.82 RXRA (0.53) SGMS2PTGER1PTGER4PTGER3PTGER2
SCHEMBL4602703 0.82 SGMS2 (0.43) GAASGMS2KMT2APTGER1PTGER4
SCHEMBL5345373 0.80 HTR1A (0.51) HTR1AADRA1DADRA1AADRA1BRAB9A
SCHEMBL1952684 0.79 HTR1A (0.63) HTR1AADRA1DADRA1AADRA1BGAA
SCHEMBL4601601 0.78 EGFR (0.47) GAAKMT2AMAPTPTPN1HTT
SCHEMBL8070513 0.77 THRB (0.41) GAAKMT2AMAPTMAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912645-A2 THERAPEUTIC AGENT FOR DIABETES Takeda Pharmaceutical Company Limited (JP) 2008-04-23 EP disclosed
WO-2007018314-A2 THERAPEUTIC AGENT FOR DIABETES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-15 WO disclosed